IMPACT OF RESPONSE TO HOLDING/BRIDGING THERAPY IN SECOND- LINE DLBCL PATIENTS TREATED WITH AXICABTAGENE CILOLEUCEL
ICML 2025 - Dr. med. Nico Gagelmann
SHOW MORE
ICML 2025 - Prof. Dr. med. Gerald Illerhaus
ICML 2025 - Univ.-Prof. Dr. med. Georg Heß